3D printing in healthcare - navigating IP, data, and liability in a custom-made world

3D printing is revolutionising medical care, enabling the creation of patient-specific devices and anatomical models that improve surgical outcomes. However, the shift from mass manufacturing to custom fabrication introduces complex legal and commercial challenges.

At a recent workshop, industry experts unpacked the implications for Intellectual Property (IP), data privacy, product liability, and regulatory compliance.

We discuss the key risks and opportunities for businesses operating in the 3D printing space.

1. Securing your IP beyond the 3D printer

The value in custom medical devices extends far beyond the physical printing process. It encompasses the entire workflow: from capturing patient imaging (CT/MRI) and generating 3D models to the algorithms used for virtual correction and final device design.

The IP landscape is complex.

A single product may rely on multiple layers of protection:

• Patents: For imaging technologies, novel materials, and algorithms.

• Registered Designs: For the physical shape of the device.

• Copyright: For the software and design files.

• Confidential Information: For the "know-how" developed by engineers and clinicians.

Strategic impact: Don't let your innovation slip away. Many companies fail to capture or protect valuable IP because they focus solely on the end product. Engaging experts early to map the IP landscape, especially regarding the patentability of software and biological materials, is critical to securing your commercial advantage.

2. Data privacy

Custom medical devices are data-driven. The workflow is entirely digital, relying on sensitive patient health information from scan to manufacture.

While privacy laws are generally technology-neutral, they impose strict obligations on handling health data. The core requirement is patient consent.

Patient consent must be specific. It needs to cover not just the creation of the patient's own device, but also the use of their data for:

• Product design improvements.

• Software modelling and simulation.

• Testing and validation.

• Future commercialisation (even if the device is replicated for other patients).

Strategic impact: Adopt a "privacy by design" approach. Data governance shouldn't be an afterthought; it needs to be baked into your workflow. Ensure you have a robust data management plan that covers retention, security, and disposal, especially when sharing data with third-party manufacturers.

3. Product liability

3D printing disrupts traditional liability models. When a device is designed by one entity, software-modeled by another, and printed by a third party (potentially even a hospital), pinpointing the "manufacturer" becomes difficult.

However, emerging global standards (such as those from the IMDRF) suggest that liability should remain with the entity that controls the production process and benefits from regulatory approval, regardless of whether the device is mass-produced or custom-made.

The AI factor

As AI begins to drive generative design and quality assurance, new questions arise. If an AI makes an "on-the-fly" adjustment during printing that leads to a defect, who is liable? While laws regarding robot liability are still evolving, businesses must currently rely on robust contracts and insurance to allocate risk.

Strategic impact: Don't leave liability to chance. Use contracts to clearly define responsibility between designers, software providers, and printers.

4. The regulatory regime

Regulation is catching up to technology. The Therapeutic Goods Administration (TGA) and international bodies are moving toward frameworks that regulate the production system rather than individual products.

This makes sense for 3D printing, where the goal is to produce a different product every time.

Strategic impact: Understand the new definitions for Personalised Medical Devices:

• Custom-made: Bespoke devices where the healthcare professional is responsible.

• Patient-matched: 3D printed devices within a specific design envelope, where the manufacturer retains responsibility.

• Adaptable: Mass-produced devices adapted by the practitioner.

Knowing where your product fits is essential for your commercial strategy and regulatory compliance.

Key takeaway

3D printing offers immense potential for personalised medicine, but commercial success requires a sophisticated approach to legal strategy. By proactively managing IP, data privacy, and liability risks, businesses can build a solid foundation for innovation.

Tips for your business:

• Survey the IP landscape: Ensure you aren't infringing on existing patents and that you are protecting your own innovations.

• Privacy by design: Build data consent and security into your workflow from day one.

• Define Liability: Use contracts to clearly allocate risk between all partners in the supply chain.

• Stay Agile: Regulatory frameworks are evolving fast; keeping abreast of TGA and international changes is a competitive advantage.